MENU
+Compare
BNXTF
Stock ticker: OTC
AS OF
Jul 24 closing price
Price
$0.42
Change
-$0.01 (-2.33%)
Capitalization
33.77M

BNXTF BIONXT SOLUTIONS INC. Forecast, Technical & Fundamental Analysis

BioNxt Solutions Inc is a cannabis company focused on next-generation drug formulations and delivery systems... Show more

BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BNXTF with price predictions
Jul 25, 2025

BNXTF in -3.73% downward trend, falling for three consecutive days on July 18, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BNXTF declined for three days, in of 156 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on July 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BNXTF as a result. In of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Aroon Indicator for BNXTF entered a downward trend on July 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BNXTF's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BNXTF just turned positive on July 09, 2025. Looking at past instances where BNXTF's MACD turned positive, the stock continued to rise in of 66 cases over the following month. The odds of a continued upward trend are .

BNXTF moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BNXTF advanced for three days, in of 139 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BNXTF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.692) is normal, around the industry mean (62.701). P/E Ratio (0.000) is within average values for comparable stocks, (88.783). BNXTF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. BNXTF's P/S Ratio (116.279) is slightly higher than the industry average of (18.372).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNXTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1820 Fir Street
Phone
+1 780 818-6422
Employees
6
Web
https://www.xphyto.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGUUF0.07N/A
N/A
Benguet Corp. BC
ESYJY6.66-0.04
-0.55%
easyJet Plc
MATEF0.10N/A
-1.31%
Blockmate Ventures Inc.
WHTCF3.41-0.06
-1.84%
Well Health Technologies Corp.
KBGGY15.23-0.38
-2.40%
Kongsberg Gruppen ASA

BNXTF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BNXTF has been loosely correlated with DRRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if BNXTF jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
N/A
DRRX - BNXTF
62%
Loosely correlated
-3.44%
HLBBF - BNXTF
27%
Poorly correlated
-3.38%
PAHC - BNXTF
26%
Poorly correlated
-0.88%
SDZXF - BNXTF
24%
Poorly correlated
N/A
AMPH - BNXTF
24%
Poorly correlated
-1.15%
More